Exclusivity depends not only on territory and price but on access to technical cooperation for the Chinese assessment. The Chinese search terms “non-medical certification” and “non-medical notice” should be understood through medical-device classification and the exact wording of the relevant document. They do not describe a general product-safety certification. This article concerns evidence preparation and business decisions; it does not establish that any particular device has received a decision not to be regulated as a medical device. A so-called non-medical notice does not replace the manufacturer’s market-entry responsibilities. Unanswered technical questions can leave exclusive rights difficult to implement.
Facts to establish
Assess commercial commitments together with access to technical evidence. The project record should identify the model, accessories, software version, manufacturer documents and technical contact. Distribution rights establish commercial rights, but do not determine the Chinese regulatory status. Payment or purchase pressure cannot justify demanding a positive classification assessment.
How to move the project forward
Payment conditions may be linked to verifiable document delivery, version confirmation and staged assessment rather than verbal assurances. Discuss what happens if records remain incomplete, the product changes or the preferred route is unsupported. Have contract professionals review the actual terms; this is a due-diligence approach, not a universal contract template.
Where records support only a preliminary assessment, identify unresolved questions and commitments that should wait. Include technical cooperation, verification costs and alternative market-entry options in the decision. Do not present a consultant’s preliminary opinion as an approval already issued by the regulator.
Decision boundaries
Negotiate a technical contact, document updates and confirmation of the Chinese version. Check how configuration changes during the agreement are communicated. Treat commercial exclusivity and factual review separately; the authorisation scope is not the scope of a classification conclusion.
For a concrete assessment, collect the model, current instructions, intended scenario and unresolved questions. Separate verified facts from assumptions before prioritising documentation, verification or actual product changes. An individual assessment does not replace a formal decision or guarantee an outcome, completion date or acceptance by every sales channel.